Symbiomix Therapeutics is a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections than can have serious health consequences. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world’s leading healthcare venture capital firms: OrbiMed, F-Prime Capital Partners, and HBM Partners. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
Medically Reviewed
ADVERTISEMENT
Viviendo con Cáncer de Seno Metastásico
Alrededor de 155,000 mujeres en los Estados Unidos viven con cáncer de seno metastásico.
20 Jan 2021
Created With Support
Blood Basics: What Happens After You Donate Blood and Why You Should Be Donating — Even During COVID-19
Consider giving blood to alleviate shortages caused by the pandemic
20 Jan 2021
Your Health
Don’t Put Off Your Screening and Vaccination for Cervical Cancer
Screening and vaccination are vital for preventing cervical cancer, and women need to know the preventive tools available
19 Jan 2021
Created With Support